Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pediatric
100%
IKZF1 Deletion
100%
Precursor B-cell Acute Lymphoblastic Leukemia
100%
Non-high Risk
40%
Oncology
20%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Treatment Protocol
20%
Therapy-resistant
20%
Clinical High Risk
20%
Pediatric Acute Lymphoblastic Leukemia
20%
Acute Lymphoblastic Leukemia
20%
Dutch
20%
Overall Survival Rate
20%
Risk Stratification
20%
Copy number
20%
Genomic Profiling
20%
Group Treatment
20%
Copy number Variation
20%
Nonsense mutation
20%
Relapse-free Survival
20%
High-resolution
20%
Most Common Cause
20%
Progenitor Cells
20%
Delayed Diagnosis
20%
PAX5
20%
EBF1
20%
Prognostic Impact
20%
DNA Copy number
20%
Future Risk
20%
Deletion mutation
20%
Relapse Rate
20%
Strong Predictor
20%
Prone Therapy
20%
Relapse Predictors
20%
Treatment Failure
20%
Working Diagnosis
20%
Separate Analysis
20%
Recurrent Lesion
20%
Biochemistry, Genetics and Molecular Biology
Precursor
100%
IKZF1
100%
Pediatrics
100%
Overall Survival
16%
Progenitor Cell
16%
Nonsense Mutation
16%
Survival Rate
16%
EBF1
16%
PAX5
16%
Gene Dosage
16%
Recurrence Free Survival
16%
Genomics
16%
Dexamethasone
16%
Cyclin Dependent Kinase Inhibitor 2A
16%